Institutional investors control 18.57% of the outstanding shares in SYN. This represents a greater percentage of ownership than at almost any other company in the Biotechnology industry. Additionally, during the quarter ended June 2017, these large investors purchased a net $6.6 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
GOLDMAN SACHS & CO. LLC (PRIVATE... Bought 1.1 Million shares of Synthetic Biologics Inc